COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

RemeGen

Biopharmaceutical company developing antibody and fusion-protein therapies for autoimmune disease, oncology and ophthalmology.

TICKER9995.HK

HEADQUARTERSYantai, China

STAGEApproved

ACTIVE TRIALS30

Therapeutic areas

AutoimmuneOncologyOphthalmology

Selected products and programs

telitaciceptdisitamab vedotin

Linked curated drug profiles

No curated drug entity is linked in the current pilot.

Selected active clinical trials

A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma

Phase 3 · Recruiting · Urothelial Carcinoma

A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)

Phase 3 · Recruiting · Myasthenia Gravis, Ocular

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

Phase 3 · Recruiting · Breast Cancer

RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)

Phase 3 · Recruiting · Non-Small Cell Lung Cancer

A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Phase 3 · Recruiting · Gastric Carcinoma

RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression

Phase 1 · Recruiting · Solid Tumor

Selected patent records

No linked FDA Orange Book patent record was found for the selected products.

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier: /companies/remegen/
Event / action date: Not separately retained
Source update date: Not separately retained
Platform retrieval / processing date: Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record